Skip to main content
. Author manuscript; available in PMC: 2020 Mar 15.
Published in final edited form as: AIDS. 2019 Mar 15;33(4):605–613. doi: 10.1097/QAD.0000000000002112

Fig. 3. Expression of activating receptors on NK cells.

Fig. 3.

NK cells were negatively isolated from thawed PBMC and stained with a panel of monoclonal antibodies to analyze the expression of activating receptors. A. VOR treatment: NKp30, DNAM-1 and NKG2D expression did not change during treatment, but expression of CD16 and NKp46 was increased to some extent after VOR administration. B. PNB treatment: No changes were observed during PNB treatment. Each symbol represents cells from a different study participant. Wilcoxon matched-pairs signed rank test.